113 related articles for article (PubMed ID: 38420804)
21. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
22. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
Liao XH; Wang Y; Zhong B; Zhu SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
[TBL] [Abstract][Full Text] [Related]
23. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
24. RBM4 promotes neuronal differentiation and neurite outgrowth by modulating Numb isoform expression.
Tarn WY; Kuo HC; Yu HI; Liu SW; Tseng CT; Dhananjaya D; Hung KY; Tu CC; Chang SH; Huang GJ; Chiu IM
Mol Biol Cell; 2016 May; 27(10):1676-83. PubMed ID: 27009199
[TBL] [Abstract][Full Text] [Related]
25. Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Chen JY; Liu LP; Xu JF
Onco Targets Ther; 2017; 10():339-345. PubMed ID: 28138257
[TBL] [Abstract][Full Text] [Related]
26. Posttranscriptional regulation of human endogenous retroviruses by RNA-binding motif protein 4, RBM4.
Foroushani AK; Chim B; Wong M; Rastegar A; Smith PT; Wang S; Barbian K; Martens C; Hafner M; Muljo SA
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26520-26530. PubMed ID: 33020268
[TBL] [Abstract][Full Text] [Related]
27. Lark is the splicing factor RBM4 and exhibits unique subnuclear localization properties.
Markus MA; Morris BJ
DNA Cell Biol; 2006 Aug; 25(8):457-64. PubMed ID: 16907643
[TBL] [Abstract][Full Text] [Related]
28. RelB is a potential molecular biomarker for immunotherapy in human pan-cancer.
Wu J; Yu X; Zhu H; Chen P; Liu T; Yin R; Qiang Y; Xu L
Front Mol Biosci; 2023; 10():1178446. PubMed ID: 37388242
[No Abstract] [Full Text] [Related]
29. The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.
Liang YC; Lin WC; Lin YJ; Lin JC
Oncotarget; 2015 Nov; 6(35):38046-60. PubMed ID: 26506517
[TBL] [Abstract][Full Text] [Related]
30. RNA-binding motif 4 promotes angiogenesis in HCC by selectively activating VEGF-A expression.
Han H; Lin T; Wang Z; Song J; Fang Z; Zhang J; You X; Du Y; Ye J; Zhou G
Pharmacol Res; 2023 Jan; 187():106593. PubMed ID: 36496136
[TBL] [Abstract][Full Text] [Related]
31. RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing.
Lin JC; Tarn WY
J Cell Biol; 2011 May; 193(3):509-20. PubMed ID: 21518792
[TBL] [Abstract][Full Text] [Related]
32. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
33. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
34. Cell stress modulates the function of splicing regulatory protein RBM4 in translation control.
Lin JC; Hsu M; Tarn WY
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2235-40. PubMed ID: 17284590
[TBL] [Abstract][Full Text] [Related]
35. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers.
Dong X; Liu T; Li Z; Zhai Y
Aging (Albany NY); 2023 Jul; 15(14):7237-7257. PubMed ID: 37498296
[TBL] [Abstract][Full Text] [Related]
36. Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer.
Li S; Qi Y; Yu J; Hao Y; Xu L; Ding X; Zhang M; Geng J
Heliyon; 2023 Jul; 9(7):e17386. PubMed ID: 37415951
[TBL] [Abstract][Full Text] [Related]
37. RNA binding motif 4 inhibits the replication of ebolavirus by directly targeting 3'-leader region of genomic RNA.
Fan L; Wang Y; Huang H; Wang Z; Liang C; Yang X; Ye P; Lin J; Shi W; Zhou Y; Yan H; Long Z; Wang Z; Liu L; Qian J
Emerg Microbes Infect; 2024 Dec; 13(1):2300762. PubMed ID: 38164794
[TBL] [Abstract][Full Text] [Related]
38. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
39. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract][Full Text] [Related]
40. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
